Wegovy (semaglutide) It was the first weekly injectable GLP-1 approved specifically for weight management in adults with a body mass index of 30 or higher, or 27 and above with at least one weight-related condition such as high blood pressure or type 2 diabetes
(PubMed) Sawicka AK, Hartmane D, Lipinska P, Wojtowicz E, Lysiak-Szydlowska W, Olek RA
Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction
Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB and BB from macro forms of creatine kinase isoenzymes in patients and healthy individuals
Essential Fatty Acids (Omega-6 and Omega-3) Essential fatty acid sufficiency and balance seem to play a key role in managing menopause symptoms
The brain is literally two percent of your whole body weight, yet it consumes twenty percent of all the oxygen you breathe in every single day